PrecisionLife announces first close of Series A financing to progress its drug discovery pipeline and commercial partnerships OXFORD, UK January 31, 2022 – PrecisionLife Limited, a global techbio company driving precision medicine in chronic disease with AI-led drug discovery, clinical development, and healthcare solutions, announces the first close of its Series A investment round. The … Continue reading PrecisionLife secures Series A investment